Effect and Mechanism of lncRNA-PCMF1/hsa-miR-137/Twist1 Axis Involved in the EMT Regulation of Prostate Cancer Cells-Reference-Cited by-同舟云学术

Effect and Mechanism of lncRNA-PCMF1/hsa-miR-137/Twist1 Axis Involved in the EMT Regulation of Prostate Cancer Cells

Published:2023-03-12 Issue:12 Volume:65 Page:1991-2003
ISSN:1073-6085
Container-title:Molecular Biotechnology
language:en
Short-container-title:Mol Biotechnol

Author:

Cui Haoyu,Hou Chuansheng,Ma Qiang,Chen Zhuo,Xie Xuefeng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s12033-023-00709-y.pdf

Reference29 articles.

1. Harshman, L. C., Chen, Y.-H., Liu, G., Carducci, M. A., Jarrard, D., Dreicer, R., Hahn, N., Garcia, J. A., Hussain, M., Shevrin, D., Eisenberger, M., Kohli, M., Plimack, E. R., Cooney, M., Vogelzang, N. J., Picus, J., Dipaola, R., & Sweeney, C. J. (2018). Seven-month prostate-specific antigen is prognostic in metastatic hormone-sensitive prostate cancer treated with androgen deprivation with or without docetaxel. Journal of clinical oncology: Official journal of the American Society of Clinical Oncology, 36, 376–382.

2. Burdett, S., Boevé, L. M., Ingleby, F. C., Fisher, D. J., Rydzewska, L. H., Vale, C. L., van Andel, G., Clarke, N. W., Hulshof, M. C., James, N. D., Parker, C. C., Parmar, M. K., Sweeney, C. J., Sydes, M. R., Tombal, B., Verhagen, P. C., & Tierney, J. F. (2019). Prostate radiotherapy for metastatic hormone-sensitive prostate cancer: A STOPCAP systematic review and meta-analysis. European urology, 76, 115–124.

3. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68, 394–424.

4. Sidaway, P. (2015). Prostate cancer: Treatment with ADT impairs cognitive performance. Nature reviews. Urology, 12, 361.

5. Barata, P., Swami, U., & Agarwal, N. (2020). The addition of apalutamide to ADT in the treatment of metastatic castration-sensitive prostate cancer: Safety and efficacy. Expert review of anticancer therapy, 20, 147–150.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of Long Non-coding RNAs in Cancer;Handbook of Cancer and Immunology;2023-11-11